Effect of guideline revisions by the Swiss Society of Hypertension on blood pressure control in hypertensive patients from primary care

被引:0
|
作者
Stephanie, Giezendanner [1 ]
Peter, Tschudi [1 ]
Jorg, Leuppi [2 ]
Thomas, Dieterle [2 ]
Andreas, Zeller [1 ]
机构
[1] Univ Basel, Ctr Primary Hlth Care, Basel, Switzerland
[2] Cantonal Hosp Baselland, Univ Dept Med, Liestal, Switzerland
关键词
guidelines; hypertension; complicated hypertension; blood pressure target; diabetes mellitus; renal dysfunction; prospective cohort study; 2013 ESH/ESC GUIDELINES; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR RISK; CLINICAL GUIDELINES; GENERAL-POPULATION; HIGH PREVALENCE; MANAGEMENT; MORTALITY; COUNTRIES; TARGETS;
D O I
10.4414/smw.2020.20279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Recommendations for blood pressure goals have considerably changed across time, in particular for high-risk patients with diabetes mellitus and/or renal dysfunction. Before 2009, Swiss Society of Hypertension (SSH) guidelines recommended lowering blood pressure to <135/85 mm Hg and after 2009 to <130/80 mm Hg in high-risk patients. It remains unclear whether guideline changes for blood pressure targets are associated with reductions in blood pressure in hypertensive patients treated in primary care. The objective was to report the association between guideline change and blood pressure target achievement, as well as the prevalence of blood pressure target achievement according to guidelines and to identify factors associated with blood pressure target achievement in a Swiss primary care sample of treated hypertensive patients. METHODS: We used longitudinal data from the Swiss Hypertension Cohort Study, which was a prospective, observational study conducted by the Centre for Primary Health Care of the University of Basel from 2006 to 2013. General practitioners (GPs) enrolled 1003 patients attending their practice with a pre-existing diagnosis of arterial hypertension or office blood pressure measurement >= 140/90 mm Hg and assessed office blood pressure, cardiovascular risk factors, subclinical organ damage, diabetes mellitus, and established cardiovascular and renal disease. Mixed-effects regression models were used to estimate the associations of (1) the change in hypertension guidelines in 2009 with blood pressure and antihypertensive therapy in high-risk patients, and (2) cardiovascular risk factors with blood pressure target achievement in patients with complicated and uncomplicated hypertension. Models were adjusted for sociodemographic and health-related covariates. Missing data were imputed using a "multiple imputation by chained equation" approach. RESULTS: At baseline, hypertensive patients were on average 65.9 +/- 12.5 years old and 55% were male. Blood pressure targets were achieved in 47% of patients with uncomplicated hypertension and in 13% of high-risk patients at baseline. In multivariable analyses adjusted for potential confounding factors, a visit by high-risk patients after 2009 was associated with decreased systolic office blood pressure (-5.40 mm Hg, 95% confidence interval [CI] -8.08 to 2.73) and a trend towards an increased use of pharmacological combination therapy (odds ratio [OR] 1.85, 95% CI 0.94 to 3.63; p = 0.073) compared with a visit before 2009. Neither a reduction of diastolic blood pressure nor an increase of blood pressure target achievement in high-risk patients was observed after 2009. High-risk patients were slightly more likely to achieve blood pressure targets at later follow-up visits than at baseline (OR 1.35, 95% CI 0.98 to 1.86; p = 0.068). In patients with uncomplicated hypertension, factors associated with the likelihood to achieve blood pressure goals were the increased use of pharmacological combination therapy (OR 1.19 per combination increase: e.g., dual therapy vs monotherapy, 95% CI 1.02 to 1.40), left ventricular hypertrophy (OR 0.58, 95% CI 0.36 to 0.93), older age (OR 1.19 per 10 years, 95% CI 1.02 to 1.40) and the number of follow-up examinations (OR 1.44 per follow-up visit, 95% CI 1.21 to 1.72). CONCLUSION: Overall, blood pressure goal attainment remains low for treated hypertensive patients followed up by primary care physicians in Switzerland. Independent of known confounding factors for blood pressure, the 2009 guideline change in high-risk patients was associated with a reduction in systolic office blood pressure together with an increase in pharmacological combination therapy. These results highlight primary care physicians' efforts to implement blood pressure guidelines. Further, blood pressure goal attainment was more likely to be achieved in later follow-up visits, indicating that it takes time and regular follow-up visits with the GP to meet blood pressure goals.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Effect of Home Telemonitoring on Glycemic and Blood Pressure Control in Primary Care Clinic Patients with Diabetes
    Wakefield, Bonnie J.
    Koopman, Richelle J.
    Keplinger, Lynn E.
    Bomar, Marilee
    Bernt, Beth
    Johanning, Jennifer L.
    Kruse, Robin L.
    Davis, J. Wade
    Wakefield, Douglas S.
    Mehr, David R.
    TELEMEDICINE AND E-HEALTH, 2014, 20 (03) : 199 - 205
  • [22] Blood pressure control and cardiovascular risk profile in hypertensive patients under specialist care in Argentina: Results from the CHARTER study
    Marin, Marcos
    Barochiner, Jessica
    Rodriguez, Pablo
    Renna, Nicolas
    Castellaro, Carlos
    Espeche, Walter
    De Cerchio, Alejandro
    Del Sueldo, Mildren
    Vissani, Sergio
    Zilberman, Judith
    JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (10) : 1456 - 1462
  • [23] Hypertension Control and Guideline-Recommended Target Blood Pressure Goal Achievement at an Early Stage of Hypertension in the UAE
    Bhagavathula, Akshaya Srikanth
    Shah, Syed Mahboob
    Suliman, Abubaker
    Oulhaj, Abderrahim
    Aburawi, Elhadi Husein
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [24] Usefulness of Home Blood Pressure in the Diagnosis and Control of Hypertension in Primary Care
    Martinez, Maria A.
    Puig, Juan G.
    CURRENT HYPERTENSION REVIEWS, 2006, 2 (01) : 41 - 46
  • [25] Blood pressure control and management of very elderly patients with hypertension in primary care settings in Spain
    Rodriguez-Roca, Gustavo C.
    Llisterri, Jose L.
    Prieto-Diaz, Miguel A.
    Alonso-Moreno, Francisco J.
    Escobar-Cervantes, Carlos
    Pallares-Carratala, Vicente
    Valls-Roca, Francisco
    Barrios, Vivencio
    Banegas, Jose R.
    Alsina, DiegoGonzalez-Segura
    HYPERTENSION RESEARCH, 2014, 37 (02) : 166 - 171
  • [26] Cardiovascular risk and blood pressure control in a Spanish hypertensive population attended in a Primary Care setting. Data from the PRESCAP 2006 study
    Rodriguez-Roca, Gustavo C.
    Llisterri-Caro, Jose L.
    Barrios-Alonso, Vivencio
    Alonso-Moreno, Francisco J.
    Lou-Arnal, Salvador
    Prieto-Diaz, Miguel A.
    Sanchez-Ruiz, Tomas
    Dura-Belinchon, Rafael
    Santos-Rodriguez, Jose A.
    Divison-Garrote, Juan A.
    Gonzalez-Segura, Diego
    Banegas-Banegas, Jose R.
    BLOOD PRESSURE, 2009, 18 (03) : 117 - 125
  • [27] Factors influencing blood pressure control in patients with atrial fibrillation and hypertension in Australian primary care
    Trivedi, Ritu
    Marschner, Simone
    Shaw, Tim
    Min, Haeri
    Yue, Jason
    Kazi, Samia
    Nguyen, Tu Ng
    Laranjo, Liliana
    Chow, Clara K.
    HEART, 2024, 110 (02) : 94 - 100
  • [28] Blood pressure control in patients with hypertension: a retrospective cohort study
    Aydogan, Umit
    Doganer, Yusuf C.
    Atik, Asli
    Rohrer, James E.
    Gok, Deniz Engin
    Cirpan, Ebru
    Yilmaz, Mahmut I.
    Saglam, Kenan
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2015, 21 (02) : 313 - 319
  • [29] Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation
    Barrios, Vivencio
    Escobar, Carlos
    Prieto Valiente, Luis
    Maria Lobos, Jose
    Vargas-Ortega, Diego
    Polo, Jose
    Marin Montanes, Nuria
    BLOOD PRESSURE, 2017, 26 (05) : 279 - 283
  • [30] Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease
    Rysavá, R
    Tesar, V
    Merta, M
    BLOOD PRESSURE MONITORING, 2005, 10 (04) : 207 - 213